Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Boer

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|November 3, 2012
Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort studyMatejka Rebolj, Theo Helmerhorst, Dik Habbema, et al.
International Journal of Cancer|September 4, 2008
No increased risk for cervical cancer after a broader definition of a negative Pap smearMatejka Rebolj, Marjolein van Ballegooijen, Folkert van Kemenade, et al.
BMJ (Clinical Research Ed.)|April 28, 2009
Incidence of cervical cancer after several negative smear results by age 50: prospective observational studyMatejka Rebolj, Marjolein van Ballegooijen, Elsebeth Lynge, et al.
International Journal of Cancer|December 3, 2008
At what costs will screening with CT colonography be competitive? A cost-effectiveness approachIris Lansdorp-Vogelaar, Marjolein van Ballegooijen, Ann G Zauber, et al.
Nature|December 13, 2006
Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnosticsYee-Wei Lim, Mark Steinhoff, Federico Girosi, et al.
BMC Nephrology|April 19, 2013
Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysisJaime L Natoli, Rob Boer, Brian H Nathanson, et al.
International Journal of Cancer|February 22, 2002
Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trialHarry J de Koning, Michael K Liem, Caroline A Baan, et al.
Cancer|August 26, 2006
How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatmentIris Vogelaar, Marjolein van Ballegooijen, Deborah Schrag, et al.
Journal of the National Cancer Institute. Monographs|October 13, 2006
The MISCAN-Fadia continuous tumor growth model for breast cancerSita Y G L Tan, Gerrit J van Oortmarssen, Harry J de Koning, et al.
The New England Journal of Medicine|December 24, 2002
A model for a smallpox-vaccination policySamuel A Bozzette, Rob Boer, Vibha Bhatnagar, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|November 3, 2012
Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort studyMatejka Rebolj, Theo Helmerhorst, Dik Habbema, et al.
International Journal of Cancer|September 4, 2008
No increased risk for cervical cancer after a broader definition of a negative Pap smearMatejka Rebolj, Marjolein van Ballegooijen, Folkert van Kemenade, et al.
BMJ (Clinical Research Ed.)|April 28, 2009
Incidence of cervical cancer after several negative smear results by age 50: prospective observational studyMatejka Rebolj, Marjolein van Ballegooijen, Elsebeth Lynge, et al.
International Journal of Cancer|December 3, 2008
At what costs will screening with CT colonography be competitive? A cost-effectiveness approachIris Lansdorp-Vogelaar, Marjolein van Ballegooijen, Ann G Zauber, et al.
Nature|December 13, 2006
Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnosticsYee-Wei Lim, Mark Steinhoff, Federico Girosi, et al.
BMC Nephrology|April 19, 2013
Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysisJaime L Natoli, Rob Boer, Brian H Nathanson, et al.
International Journal of Cancer|February 22, 2002
Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trialHarry J de Koning, Michael K Liem, Caroline A Baan, et al.
Cancer|August 26, 2006
How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatmentIris Vogelaar, Marjolein van Ballegooijen, Deborah Schrag, et al.
Journal of the National Cancer Institute. Monographs|October 13, 2006
The MISCAN-Fadia continuous tumor growth model for breast cancerSita Y G L Tan, Gerrit J van Oortmarssen, Harry J de Koning, et al.
The New England Journal of Medicine|December 24, 2002
A model for a smallpox-vaccination policySamuel A Bozzette, Rob Boer, Vibha Bhatnagar, et al.
Pageof 4